5 Digital Health Topics Trending Right Now: by Kate Rodgers | March 13th, 2017 Imagine sitting down at your next, dreaded doctor’s appointment, and having your physician walk in and hand you a virtual reality head set before you undergo your procedure. It may seem crazy, but many of the digital health technologies that are […]

Read the full press release here.  Milwaukee, WI (March 07, 2017) – [m]pirik announced today that Allscripts has certified Ortho[m]atrix as part of the Allscripts Developer Program. Ortho[m]atrix, enables Allscripts users to maximize the value of orthopedic procedures by collecting and analyzing data from the patient’s continuum of care, specifically for ambulatory orthopedic surgery centers […]

Original article from Xconomy. By Jeff Buchanan.  Epic Systems, which sells software for managing health records that is used to care for 190 million patients around the world, has introduced a new program that the company says will help outside healthcare software developers integrate their digital tools with Epic’s. The program, called App Orchard, aims […]

Semba Biosciences introduces a new multicolumn continuous chromatography platform; dramatically reducing the cost to develop and manufacture biological drugs. MADISON, WI (January 24, 2017) – Semba Biosciences is proud to introduce its versatile and easy to use multicolumn continuous chromatography platform for process development and GMP compliant, single-use manufacturing. Many of the latest drug candidates […]

The United States has long been a leader in medical technology innovation and discovery, and Wisconsin has been a leading state in medical breakthroughs and medical device manufacturing. Unfortunately, we have tax policies, including the medical device tax, that have stifled innovation and job creation, putting our research and technological leadership at risk. Fortunately, lawmakers […]

– This marks the seventh FDA approval and fifth disease indication for IMBRUVICA since the medication’s initial approval in 2013 – IMBRUVICA will be a chemotherapy-free option for patients with MZL who failed prior therapies NORTH CHICAGO, Ill., Jan. 19, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the U.S. Food […]